Beta-receptor blockaders and chronic obstructive respiratory tract diseases
Lohmann, F.W.
Deutsche Medizinische Wochenschrift 119(11): 404; Author Reply 405
1994
ISSN/ISBN: 0012-0472 PMID: 7907544 Document Number: 428855
Document emailed within 1 workday
Related Documents
Rieben, F.W. 1981: Chronic obstructive respiratory tract and lung diseases Zfa. Zeitschrift für Allgemeinmedizin 57(29): 1956-1964Klech, H.; Kummer, F. 1994: Smoking causes chronic obstructive lung diseases and increased infections of the respiratory tract Wiener Medizinische Wochenschrift 144(22-23): 535-540
Worth, H.; Petro, W. 1998: Recommendations for structure and contents of train-the-trainer seminars for educating patients with chronic obstructive respiratory tract diseases Pneumologie 52(8): 473-474
Gerc, V. 1977: Beta blockaders and cardiovascular diseases. use of beta blockaders in hypertension Medicinski Arhiv 31(1): 21-24
1994: Glucocorticoid therapy in obstructive respiratory tract diseases. German Respiratory League Pneumologie 48 Suppl. 1: 334-337
Dück, K.; Strube, G.; Knappe, J. 1976: Therapy of chronic ischemic heart disease and arterial hypertension by means of beta-receptor blockaders Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(3): 324-327
Bragina, G.I. 1981: Effectiveness of the combined use of adrenergic beta receptor blockaders and long-acting nitrates in chronic ischemic heart disease Klinicheskaia Meditsina 59(11): 36-42
Rambauske, F. 1971: New treatment possibilities in obstructive respiratory tract diseases Wiener Medizinische Wochenschrift 121(3): 36-37
Morr, H. 1979: RAST in the differential diagnosis of obstructive respiratory tract diseases Zeitschrift für Hautkrankheiten 54(4): 136-143
Heinl, K.W. 1989: Obstructive respiratory tract diseases. Diagnosis and principles of therapy Medizinische Monatsschrift für Pharmazeuten 12(11): 338-343
Möller, M. 1987: Short-term therapy with methylprednisolone in exacerbated obstructive respiratory tract diseases Praxis und Klinik der Pneumologie 41(1): 19-22
Barthel, E. 1983: Current dosed aerosols in the treatment of obstructive respiratory tract diseases. 1. Intal Zeitschrift für Arztliche Fortbildung 77(17): 721-723
Heide, D. 1984: Modern aerosols in the treatment of obstructive respiratory tract diseases. 3. Inhalable corticoids Zeitschrift für Arztliche Fortbildung 78(2): 49-51
Owsiński, J.; Dolezal, M.; Dolezal, M. 1972: Fungi of the upper respiratory tract and the incidence of chronic respiratory diseases in workers of gypsum industry. I Przeglad Lekarski 29(4): 467-471
Wiatr, E. 1981: Phagocytosis and nitroblue tetrazolium reduction tests in respiratory tract diseases. II. Disorders of granulocyte function in respiratory tract diseases Pneumonologia Polska 49(6): 417-425
Chodosowska, E.; Hawryłkiewicz, I.; Pepke, J.; Biernacki, W.; Zieliński, J. 1983: Pulmonary artery pressure and respiratory function in patients with chronic respiratory tract diseases 6 years after the first test Pneumonologia Polska 51(2): 93-99
Eckardt, R.; Carstens, E.; Fiedler, W. 1975: Synthesis of new beta 1-receptor blockaders Die Pharmazie 30(10): 633-637
Kaik, G. 1977: Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline Schweizerische Medizinische Wochenschrift 107(52): 1948-1957
Ljungström, A.; Aberg, H. 1973: Interaction between beta receptor blockaders and verapamil Lakartidningen 70(41): 3548
Fabel, H. 1971: Beta-receptor blockaders and asthma bronchiale Deutsche Medizinische Wochenschrift 96(5): 220-221